25 of the Best Oncologists Near Me

Eric Sorenson, MD, FACS is a cancer surgeon with dual board certifications in surgical oncology and general surgery. His expertise is in abdominal surgical oncology, with a specific focus on cancerous and benign tumors of the pancreas, stomach, adrenal gland, gallbladder, liver, and intestine. He performs both minimally invasive (laparoscopic) and standard (open) surgical procedures. Dr. Sorenson enthusiastically supports the multidisciplinary team approach to the care of cancer patients, and he enjoys working with outstanding Intermountain colleagues in medical oncology, radiation oncology, and others in delivering the best possible care to patients with challenging diagnoses. Dr. Sorenson is highly rated in 1 condition, according to our data. His clinical expertise encompasses Stomach Cancer, Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatectomy, and Splenectomy. Dr. Sorenson is board certified in American Board Of Internal Medicine, American Board Of Surgery , and American Board Of Surgery. Dr. Sorenson is currently accepting new patients.

Victoria Vardell, MD is a hematology and oncology physician at Intermountain Health’s LDS Hospital Blood & Marrow Transplant Clinic and Medical Oncology Clinic in Salt Lake City, Utah. She supports patients in Salt Lake City, North Salt Lake, Bountiful, Sugar House, and surrounding communities treating the full spectrum of hematology, ranging from benign classical hematology to myeloid malignancies, myeloproliferative neoplasms, myelodysplastic syndromes, and bone marrow failure syndromes. She has a particular interest in acute leukemias, especially acute lymphoblastic leukemia in adults, and the role of hematopoietic stem cell transplantation.Even with expertise in treating a wide range of conditions, Dr. Vardell is especially drawn to caring for patients with acute leukemias and other complex, high-acuity conditions. These cases often require fast, thoughtful decision-making and close collaboration with patients and their families, which she finds deeply meaningful. She values the opportunity to be fully present during some of the most critical moments in a person’s care and to help guide them through both the challenges and the possibilities of treatment.With roots in Idaho, Wyoming, and now Utah, Dr. Vardell feels a deep connection to the Mountain West and its people. She is dedicated to bringing highly specialized hematology care to patients across the region, particularly those from rural areas who often face the greatest barriers to access.Dr. Vardell was born in New Mexico, spent a part of her childhood on Vashon Island in Washington, and grew up in Sandpoint, Idaho. Outside the clinic she enjoys mountain biking, hiking, skiing, and spending time with her two pugs.Conditions Treated: Benign classical hematologyMyeloid malignanciesMyeloproliferative neoplasmsMyelodysplastic syndromesBone marrow failure syndromesAcute leukemiasAcute lymphoblastic leukemia in adultsProcedures Performed: Hematopoietic stem cell transplantation. Dr. Vardell is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Prolymphocytic Leukemia, Leukemia, Non-Hodgkin Lymphoma, and Philadelphia-Negative Chronic Myeloid Leukemia. Dr. Vardell is board certified in American Board Of Internal Medicine. Dr. Vardell is currently accepting new patients.

Peter Polewski is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Polewski is highly rated in 1 condition, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Thrombocytopenia. Dr. Polewski is board certified in American Board Of Internal Medicine. Dr. Polewski is currently accepting new patients.

Mohamed Samour is an Oncologist practicing medicine in Wilkes Barre, Pennsylvania. Dr. Samour is highly rated in 1 condition, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Myelodysplastic Syndrome (MDS), Acute Monoblastic Leukemia (AmoL), and Acute Myeloid Leukemia (AML). Dr. Samour is currently accepting new patients.

Wendy Mahone-Johnson is a Hematologist and an Oncologist practicing medicine in Plano, Texas. Dr. Mahone-Johnson is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Mahone-Johnson is currently accepting new patients.

Dr. Ryan Moy is an Assistant Professor of Medicine and medical oncologist at Columbia University Irving Medical Center where he specializes in the treatment of gastrointestinal malignancies, with a focus on esophageal and stomach cancers. He received his MD/PhD from the University of Pennsylvania and completed internship and residency training in Internal Medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He then completed fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center and postdoctoral research at The Rockefeller University.  Dr. Moy is actively involved in translational research to understand the biological mechanisms that regulate metastasis, the primary driver of mortality in gastrointestinal cancers. He has performed laboratory-based research to define critical genes that promote liver metastasis in colorectal cancer. He is also conducting research to discover key vulnerabilities in esophageal and gastric cancers, with the goal of translating these findings from the lab to develop more effective treatments for patients. As an active member of the gastrointestinal oncology and experimental therapeutics groups, Dr. Moy is involved in developing and leading clinical trials investigating novel targeted and immunotherapy treatments for esophagogastric cancer and other malignancies. His work has been recognized by several awards including a Damon Runyon Cancer Research Foundation Fellow Award and a National Cancer Institute (NCI) K08 Career Development Award.  Dr. Moy works as part of a multidisciplinary team with the mission of delivering compassionate and state-of-the-art oncologic care to each patient, using a precision medicine approach to provide innovative and promising treatments. Dr. Moy is highly rated in 1 condition, according to our data. His clinical expertise encompasses Stomach Cancer, Esophageal Cancer, Fibrolamellar Carcinoma, and Colorectal Cancer. Dr. Moy is currently accepting new patients.

Niraj Shenoy is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Shenoy is highly rated in 1 condition, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Shenoy is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Shenoy is currently accepting new patients.

Dr. Jenkins obtained his Bachelor's degree in biology at the University of Virginia in 2002 and his MD/PhD at the Medical University of South Carolina in 2012. He completed his internship and residency in Internal Medicine at Massachusetts General Hospital in 2014 and his clinical oncology training in the Dana-Farber/Harvard Cancer Center in 2017. He conducted his post-doctoral research in Dr. David Barbie's lab at the Dana-Farber Cancer Institute where he developed a novel platform to study ex vivo response to PD1- blockade using organotypic tumor spheroids. In 2018, he joined the faculty at the MGH Cancer Center in the Center for Melanoma and Center for Cancer Research and was an Associate Member of the Cancer Program at the Broad Institute of MIT and Harvard. Dr. Jenkins was the inaugural Termeer Early Career Investigator in Systems Pharmacology, and member of the Laboratory for Systems Pharmacology at Harvard Medical School. Dr. Jenkins returned to MUSC in 2025 as the Cecilia and Vincent Peng Endowed Chair in Melanoma and Cutaneous Oncology with appointments in the Department of Medicine, Division of Hematology-Oncology, Department of Dermatology and Dermatologic Surgery, and Department of Pharmacology \& Immunology. The Jenkins laboratory studies mechanisms of response and resistance to immune checkpoint blockade and adoptive cellular therapy with a focus on developing rational combination therapies to overcome resistance to cancer immunotherapy. Dr. Jenkins is highly rated in 1 condition, according to our data. His clinical expertise encompasses Melanoma, Niemann-Pick Disease, Non-Langerhans-Cell Histiocytosis, and Melanoma of the Eye. Dr. Jenkins is currently accepting new patients.

Adarsh Hiremath is a Hematologist and an Oncologist practicing medicine in Gastonia, North Carolina. Dr. Hiremath is highly rated in 1 condition, according to our data. His clinical expertise encompasses Multiple Myeloma, Thrombocytopenia, Small Lymphocytic Lymphoma (SLL), and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Hiremath is board certified in American Board Of Internal Medicine, Hematology, American Board Of Internal Medicine, and American Board Of Internal Medicine, Medical Oncology. Dr. Hiremath is currently accepting new patients.

My clinical and research interests focus on disorders caused by telomere dysfunction. Our goal is to define approaches to surveillance, diagnosis and treatment for patients with telomere-mediated disease. Human syndromes associated with telomere shortening were first identified in the context of dyskeratosis congenita, a premature aging syndrome that predisposes to cancer. Dyskeratosis congenita patients and patients with telomere-mediated syndromes have an increased risk for developing certain malignancies which include myelodysplastic syndromes, myeloid leukemia and squamous cell carcinomas of the upper aerodigestive tract. The Telomere Clinic at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins provides multi-disciplinary care to patients who are suspected to have or who carry the diagnosis of telomere-related disorders. These disorders include individuals with cancer, bone marrow failure/aplastic anemia, lung disease including idiopathic pulmonary fibrosis and liver cirrhosis, among others. Our clinic brings together geneticists, genetic counselors, and we work closely with expert physicians in adult and pediatric hematology, bone marrow transplant, pulmonary medicine, lung transplant medicine, hepatology, and otolaryngology. Together, our team has established expertise in the management of these disorders and is at the forefront of leading the effort to individualize care for affected patients and their families. My group also has ongoing research efforts which include a long-term study to understand the genetics and spectrum of telomere disorders through a Registry which has been based at Johns Hopkins since 2005. Dr. Armanios is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Emphysema, Teratoma of the Mediastinum, and Myelodysplastic Syndrome (MDS). Dr. Armanios is board certified in American Board Of Internal Medicine. Dr. Armanios is currently accepting new patients.

Dr. Jafar Al-Mondhiry is a medical oncologist board certified in medical oncology, hematology and internal medicine. He joined Inova in 2022 and has been practicing since 2015. Prior to joining Inova, Dr. Al-Mondhiry worked as an Assistant Professor of Clinical Medicine for the Norris Comprehensive Cancer Center at the University of Southern California Keck School of Medicine in Los Angeles, CA. Dr. Al-Mondhiry specializes in the treatment of cutaneous malignancies, including melanoma, merkel cell carcinoma, advanced squamous cell and basal cell carcinomas, and cutaneous lymphomas. His clinical research interests focus on new medical therapies for patients with metastatic melanoma, merkel cell carcinoma, and advanced cutaneous squamous cell carcinoma, particularly in the neoadjuvant space. Other areas of interest include medical education, medical ethics, communication skills training (CST), and palliative/supportive care for patients with advanced cancers. He co-leads the ASCO Palliative Care Communities of Practice. Dr. Al-Mondhiry leads the psycho-oncology curriculum for the Inova hematology/oncology fellowship program, engaging fellows in didactic presentations, narrative medicine discussions, CST, and patient support group attendance, highlighting the human aspects of cancer care—for both patients and their oncologists. In his free time, he enjoys running, doing yoga, weightlifting, practicing meditation, podcasting on topics in the medical humanities and creative nonfiction writing with pieces published in many different outlets for medical humanities. He is the father of three wonderful girls. Dr. Al-Mondhiry is highly rated in 1 condition, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Al-Mondhiry is currently accepting new patients.

Dr. Michael Cole is a distinguished graduate of the US Air Force Academy (2006), and as an Alberta Bart Holaday Scholar went on to complete his Doctor of Philosophy in Biochemistry (2010) at University of Oxford under the direction of Prof Paul Wentworth Jr. and Prof Bob Sim. He focused his research on peptide chemistry and acyl group reactivity in thioester-containing proteins such as complement proteins, C3 and C4. He fulfilled his Air Force commitment as a chemist and Assistant Professor of Chemistry at the US Air Force Academy. He came to Johns Hopkins University for medical school in 2014. Since that time, he has stayed at Johns Hopkins completing his medical degree (2018), internal medicine residency training (2021), and hematology fellowship (2024). In 2024, he joined the Division of Hematology as an Instructor. Dr. Cole is highly rated in 1 condition, according to our data. His clinical expertise encompasses Atypical Hemolytic Uremic Syndrome (aHUS) and Thrombocytopenia. Dr. Cole is board certified in American Board Of Internal Medicine. Dr. Cole is currently accepting new patients.

Alison Garrett, MD, specializes in gynecologic oncology and is board certified in obstetrics and gynecology by the American Board of Obstetrics and Gynecology. She is affiliated with UPMC Magee-Womens Hospital, UPMC Hamot, UPMC Passavant, UPMC Presbyterian, UPMC Shadyside and UPMC Mercy. Dr. Garrett completed her medical education at Penn State University College of Medicine and residency and fellowship at University of Pittsburgh School of Medicine. Dr. Garrett is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, and Vulvar Cancer. Dr. Garrett is board certified in American Board Of Obstetrics And Gynecology. Dr. Garrett is currently accepting new patients.

Dr. Snehal Desai is a radiation oncologist. He is an Associate Professor of Radiation Oncology at Baylor College of Medicine. Dr. Desai received his medical degree from Baylor College of Medicine, where he also completed an internship in internal medicine and his residency in radiation oncology. Dr. Desai is board-certified in Radiation Oncology by the American Board of Radiology. Dr. Desai is highly rated in 1 condition, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Gallbladder Adenocarcinoma, Gallbladder Cancer, and Fibrolamellar Carcinoma. Dr. Desai is currently accepting new patients.

Kathleen Degen is an Oncologist and a Hematologist Oncology provider practicing medicine in Philadelphia, Pennsylvania. Dr. Degen is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Intraductal Papilloma, Iron Deficiency Anemia, Leukemoid Reaction, Pulmonary Embolism, and Tissue Biopsy. Dr. Degen is board certified in Hematology/Oncology and Internal Medicine. Dr. Degen is currently accepting new patients.

Dr. Tesch is a medical oncologist specialized in breast cancer at Dana-Farber Cancer Institute. She completed her medical oncology training at BC Cancer, Vancouver, British Columbia, Canada, where she served as Chief Resident in her final year, and Dana-Farber Cancer Institute. Her research focuses on investigating unique clinical and biological aspects that contribute to disparities in outcomes for young adults with breast cancer. Dr. Tesch is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Breast Cancer and Mesothelioma. Dr. Tesch is board certified in Internal Medicine and Medical Oncology. Dr. Tesch is currently accepting new patients.

Ana Lopez is an Oncologist and an Integrative Medicine provider practicing medicine in Sewell, New Jersey. Dr. Lopez is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Malignant Peripheral Nerve Sheath Tumor, and Inflammatory Breast Cancer. Dr. Lopez is board certified in Medical Oncology. Dr. Lopez is currently accepting new patients.

“The cancer journey is not a sprint, but a marathon. I am drawn to the field of hematology and oncology because I get to know my patients, to know their loved ones, and to share the hopes and strengths to face the ups and downs throughout the cancer journey. With my team, I am dedicated to bringing the latest science and technology to my patients and developing personalized plans to care for their unique needs.”. Dr. Zhu is highly rated in 1 condition, according to our data. His clinical expertise encompasses Malabsorption, Thrombocytopenia, Pulmonary Embolism, and Agranulocytosis. Dr. Zhu is board certified in   and Medical Oncology & Hematology, Internal Medicine, American Board Of Internal Medicine. Dr. Zhu is currently accepting new patients.

Zachary Pounders is a Hematologist Oncology specialist and a Hematologist practicing medicine in Greenville, Michigan. Dr. Pounders is highly rated in 1 condition, according to our data. His clinical expertise encompasses Post-Splenectomy Syndrome, Thrombocytopenia, Pulmonary Embolism, and Factor V Leiden Thrombophilia. Dr. Pounders is board certified in American Board Of Internal Medicine. Dr. Pounders is currently accepting new patients.

"Marisa Dahlman, MD, is a board-certified OB/GYN with a focused practice designation in minimally invasive gynecologic surgery (MIGS). This allows her to do complicated surgery with great precision and to provide really good outcomes for her patients. She has special medical interest in abnormal bleeding, uterine fibroids, endometriosis and abnormal Pap smears. She enjoys the opportunity to see patients over time and develop meaningful relationships with them.Most of what Dr. Dahlman does involves improving the quality of life for her patients. With this in mind, she stresses listening to her patients because she feels they are in the best position to tell her what that means for them. There is no ""one size fits all"" approach. Any decisions about surgery, hormones, medications or observation are always going to be made after looking at her patient’s entire life situation.When not busy with her practice, Dr. Dahlman enjoys cooking, reading, singing, and spending time with her husband and children.Now offeringtranscervical fibroid ablation (TFA). An outpatient procedure, TFA is an incisionless, fibroid treatment that preserves the uterus for patients.". Dr. Dahlman is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Endometrial Polyps, Uterine Fibroids, Endometriosis, Hysterectomy, and Intrauterine Device Insertion. Dr. Dahlman is board certified in American Board Of Obstetrics & Gynecology. Dr. Dahlman is currently accepting new patients.

Meng Zhao, MD, PhD, joined Providence Swedish in July 2020. She received her medical degree from the Tongji University School of Medicine in Shanghai, China. Dr. Zhao completed an Internal Medicine Residency at the University of Texas Southwestern Medical Center, and then went on to study Oncology and Hematology at The Ohio State University Comprehensive Cancer Center and Wexner Medical Center in Columbus, OH. She is board certified by the American Board of Medical Oncology, and the American Board of Hematology. She is also a member of the American Society of Clinical Oncology. She earned a PhD in Cell and Molecular Biology at the University of Texas at Austin in Austin, TX. Philosophy of Care: Dr. Zhao focuses on personalized care and shared decision-making. She engages in open dialogues with patients and their families to discuss diagnoses and treatment options. Dr. Zhao blends clinical excellence with compassion and empathy. Her mission is to enhance the outcomes and quality of life for cancer patients and their families throughout their journey. Dr. Zhao, a skilled clinical researcher, previously held the role of clinical research director and principal investigator for diverse clinical trials. Now, in Swedish Cancer Institute, she continues her cancer research journey, benefiting patients with a robust clinical trials program and cutting-edge treatments. Dr. Zhao is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Pleuropulmonary Blastoma, Lung Cancer, and Breast Cancer. Dr. Zhao is board certified in American Board Of Internal Medicine. Dr. Zhao is currently accepting new patients.

Olga Filippova is an Oncologist practicing medicine in New York, New York. Dr. Filippova is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Ovarian Cancer, Vaginal Cancer, Vulvar Cancer, Endometrial Cancer, and Splenectomy. Dr. Filippova is board certified in American Board Of Obstetrics & Gynecology. Dr. Filippova is currently accepting new patients.

Dr. Shelly Sharma is a radiation oncologist. She is an Assistant Professor of Radiation Oncology at Baylor College of Medicine. Dr. Sharma completed her residency in radiation oncology at Baylor College of Medicine. She is board-certified in Radiation Oncology by the American Board of Radiology. In addition to English, Dr. Sharma speaks Hindi, Urdu, and Punjabi. Dr. Sharma is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Malignant Mixed Mullerian Tumor, and Endometrial Cancer. Dr. Sharma is currently accepting new patients.

Fatemeh Ardeshir-Larijani is an Oncologist practicing medicine in Atlanta, Georgia. Dr. Ardeshir-Larijani is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Thymic Epithelial Tumor, Small Cell Lung Cancer (SCLC), Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Ardeshir-Larijani is board certified in American Board Of Internal Medicine, 2023. Dr. Ardeshir-Larijani is currently accepting new patients.

Ian Garrahy is an Oncologist and a Hematologist practicing medicine in Yardley, Pennsylvania. Dr. Garrahy is highly rated in 1 condition, according to our data. His clinical expertise encompasses Iron Deficiency Anemia, Acute Myelomonocytic Leukemia, Thrombocytopenia, Pulmonary Embolism, and Mastoidectomy. Dr. Garrahy is board certified in Medical Oncology, 2023, Internal Medicine, 2020, American Board Of Internal Medicine, and Hematology, 2023. Dr. Garrahy is currently accepting new patients.